APO Research
Talk to an analyst

APO RESEARCH · REPORT

General Medicines

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global General Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

30 December 2025194 pages

Choose your research edition.

Industry ResearchGeneral Medicines Industry Research Report 2026147 pages · $2,950 USDIndustry Growth & TrendsGlobal General Medicines Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal General Medicines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal General Medicines Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal General Medicines Market Analysis and Forecast 2026-2032218 pages · $4,950 USD

Market perspective

The global General Medicines market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for General Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for General Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for General Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for General Medicines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of General Medicines include Sun Pharmaceutical, Sanofi, Johnson & Johnson, Novartis, Merck, Roche, Eli Lilly, Pfizer and Jiangsu Hengrui Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global General Medicines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of General Medicines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents General Medicines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the General Medicines market size, projected growth trends, production technologies, key applications, and end-use industries.

General Medicines Segment by Company

Sun Pharmaceutical

Sanofi

Johnson & Johnson

Novartis

Merck

Roche

Eli Lilly

Pfizer

Jiangsu Hengrui Medicine

Bayer

Amgen

AbbVie

AstraZeneca

Zoetis

Vertex Pharmaceuticals

Takeda Pharmaceutical

Seagen

Regeneron Pharmaceuticals

Novo Nordisk

Moderna

Lonza

Horizon Therapeutics

GlaxoSmithKline

Gilead Sciences

Daiichi Sankyō

CVS Health

Chugai Pharmaceutical

Bristol-Myers Squibb

Biogen

Argenx

General Medicines Segment by Type

Over-the-Counter (OTC)

Prescription (Rx)

General Medicines Segment by Application

Antihypertensives

Antibiotics

Antidiabetic Drugs

Antipyretics

Analgesics

Others

General Medicines Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global General Medicines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of General Medicines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of General Medicines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the General Medicines market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of General Medicines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of General Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of General Medicines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. General Medicines Industry Trends Table 2. General Medicines Industry Drivers Table 3. General Medicines Industry Opportunities and Challenges Table 4. General Medicines Industry Restraints Table 5. Global General Medicines Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global General Medicines Revenue Market Share by Manufacturers (2021-2026) Table 7. Global General Medicines Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global General Medicines Sales Market Share by Manufacturers Table 9. Global General Medicines Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global General Medicines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global General Medicines Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global General Medicines Manufacturers, Product Type & Application Table 13. Global General Medicines Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global General Medicines by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Over-the-Counter (OTC) Table 17. Major Manufacturers of Prescription (Rx) Table 18. Global General Medicines Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global General Medicines Sales by Type (2021-2026) & (K Units) Table 20. Global General Medicines Sales by Type (2027-2032) & (K Units) Table 21. Global General Medicines Sales Market Share by Type (2021-2026) Table 22. Global General Medicines Sales Market Share by Type (2027-2032) Table 23. Global General Medicines Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global General Medicines Revenue by Type (2021-2026) & (K Units) Table 25. Global General Medicines Revenue by Type (2027-2032) & (K Units) Table 26. Global General Medicines Revenue Market Share by Type (2021-2026) Table 27. Global General Medicines Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Antihypertensives Table 29. Major Manufacturers of Antibiotics Table 30. Major Manufacturers of Antidiabetic Drugs Table 31. Major Manufacturers of Antipyretics Table 32. Major Manufacturers of Analgesics Table 33. Major Manufacturers of Others Table 34. Global General Medicines Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global General Medicines Sales by Application (2021-2026) & (K Units) Table 36. Global General Medicines Sales by Application (2027-2032) & (K Units) Table 37. Global General Medicines Sales Market Share by Application (2021-2026) Table 38. Global General Medicines Sales Market Share by Application (2027-2032) Table 39. Global General Medicines Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global General Medicines Revenue by Application (2021-2026) & (K Units) Table 41. Global General Medicines Revenue by Application (2027-2032) & (K Units) Table 42. Global General Medicines Revenue Market Share by Application (2021-2026) Table 43. Global General Medicines Revenue Market Share by Application (2027-2032) Table 44. Global General Medicines Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global General Medicines Sales by Region (2021-2026) & (K Units) Table 46. Global General Medicines Sales Market Share by Region (2021-2026) Table 47. Global General Medicines Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global General Medicines Sales Forecasted Market Share by Region (2027-2032) Table 49. North America General Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America General Medicines Sales by Country (2021-2026) & (K Units) Table 51. North America General Medicines Sales by Country (2027-2032) & (K Units) Table 52. Europe General Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe General Medicines Sales by Country (2021-2026) & (K Units) Table 54. Europe General Medicines Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific General Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific General Medicines Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific General Medicines Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa General Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa General Medicines Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa General Medicines Sales by Country (2027-2032) & (K Units) Table 61. Global General Medicines Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global General Medicines Revenue by Region (2021-2026) & (US$ Million) Table 63. Global General Medicines Revenue by Region (2027-2032) & (US$ Million) Table 64. Global General Medicines Revenue Market Share by Region (2021-2026) Table 65. Global General Medicines Revenue Market Share by Region (2027-2032) Table 66. Sun Pharmaceutical Company Information Table 67. Sun Pharmaceutical Business Overview Table 68. Sun Pharmaceutical General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. Sun Pharmaceutical General Medicines Product Portfolio Table 70. Sun Pharmaceutical Recent Development Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Sanofi General Medicines Product Portfolio Table 75. Sanofi Recent Development Table 76. Johnson & Johnson Company Information Table 77. Johnson & Johnson Business Overview Table 78. Johnson & Johnson General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Johnson & Johnson General Medicines Product Portfolio Table 80. Johnson & Johnson Recent Development Table 81. Novartis Company Information Table 82. Novartis Business Overview Table 83. Novartis General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Novartis General Medicines Product Portfolio Table 85. Novartis Recent Development Table 86. Merck Company Information Table 87. Merck Business Overview Table 88. Merck General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Merck General Medicines Product Portfolio Table 90. Merck Recent Development Table 91. Roche Company Information Table 92. Roche Business Overview Table 93. Roche General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Roche General Medicines Product Portfolio Table 95. Roche Recent Development Table 96. Eli Lilly Company Information Table 97. Eli Lilly Business Overview Table 98. Eli Lilly General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Eli Lilly General Medicines Product Portfolio Table 100. Eli Lilly Recent Development Table 101. Pfizer Company Information Table 102. Pfizer Business Overview Table 103. Pfizer General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Pfizer General Medicines Product Portfolio Table 105. Pfizer Recent Development Table 106. Jiangsu Hengrui Medicine Company Information Table 107. Jiangsu Hengrui Medicine Business Overview Table 108. Jiangsu Hengrui Medicine General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Jiangsu Hengrui Medicine General Medicines Product Portfolio Table 110. Jiangsu Hengrui Medicine Recent Development Table 111. Bayer Company Information Table 112. Bayer Business Overview Table 113. Bayer General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Bayer General Medicines Product Portfolio Table 115. Bayer Recent Development Table 116. Amgen Company Information Table 117. Amgen Business Overview Table 118. Amgen General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Amgen General Medicines Product Portfolio Table 120. Amgen Recent Development Table 121. AbbVie Company Information Table 122. AbbVie Business Overview Table 123. AbbVie General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. AbbVie General Medicines Product Portfolio Table 125. AbbVie Recent Development Table 126. AstraZeneca Company Information Table 127. AstraZeneca Business Overview Table 128. AstraZeneca General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. AstraZeneca General Medicines Product Portfolio Table 130. AstraZeneca Recent Development Table 131. Zoetis Company Information Table 132. Zoetis Business Overview Table 133. Zoetis General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Zoetis General Medicines Product Portfolio Table 135. Zoetis Recent Development Table 136. Vertex Pharmaceuticals Company Information Table 137. Vertex Pharmaceuticals Business Overview Table 138. Vertex Pharmaceuticals General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. Vertex Pharmaceuticals General Medicines Product Portfolio Table 140. Vertex Pharmaceuticals Recent Development Table 141. Takeda Pharmaceutical Company Information Table 142. Takeda Pharmaceutical Business Overview Table 143. Takeda Pharmaceutical General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Takeda Pharmaceutical General Medicines Product Portfolio Table 145. Takeda Pharmaceutical Recent Development Table 146. Seagen Company Information Table 147. Seagen Business Overview Table 148. Seagen General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 149. Seagen General Medicines Product Portfolio Table 150. Seagen Recent Development Table 151. Regeneron Pharmaceuticals Company Information Table 152. Regeneron Pharmaceuticals Business Overview Table 153. Regeneron Pharmaceuticals General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 154. Regeneron Pharmaceuticals General Medicines Product Portfolio Table 155. Regeneron Pharmaceuticals Recent Development Table 156. Novo Nordisk Company Information Table 157. Novo Nordisk Business Overview Table 158. Novo Nordisk General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 159. Novo Nordisk General Medicines Product Portfolio Table 160. Novo Nordisk Recent Development Table 161. Moderna Company Information Table 162. Moderna Business Overview Table 163. Moderna General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 164. Moderna General Medicines Product Portfolio Table 165. Moderna Recent Development Table 166. Lonza Company Information Table 167. Lonza Business Overview Table 168. Lonza General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 169. Lonza General Medicines Product Portfolio Table 170. Lonza Recent Development Table 171. Horizon Therapeutics Company Information Table 172. Horizon Therapeutics Business Overview Table 173. Horizon Therapeutics General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 174. Horizon Therapeutics General Medicines Product Portfolio Table 175. Horizon Therapeutics Recent Development Table 176. GlaxoSmithKline Company Information Table 177. GlaxoSmithKline Business Overview Table 178. GlaxoSmithKline General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 179. GlaxoSmithKline General Medicines Product Portfolio Table 180. GlaxoSmithKline Recent Development Table 181. Gilead Sciences Company Information Table 182. Gilead Sciences Business Overview Table 183. Gilead Sciences General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 184. Gilead Sciences General Medicines Product Portfolio Table 185. Gilead Sciences Recent Development Table 186. Daiichi Sankyō Company Information Table 187. Daiichi Sankyō Business Overview Table 188. Daiichi Sankyō General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 189. Daiichi Sankyō General Medicines Product Portfolio Table 190. Daiichi Sankyō Recent Development Table 191. CVS Health Company Information Table 192. CVS Health Business Overview Table 193. CVS Health General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 194. CVS Health General Medicines Product Portfolio Table 195. CVS Health Recent Development Table 196. Chugai Pharmaceutical Company Information Table 197. Chugai Pharmaceutical Business Overview Table 198. Chugai Pharmaceutical General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 199. Chugai Pharmaceutical General Medicines Product Portfolio Table 200. Chugai Pharmaceutical Recent Development Table 201. Bristol-Myers Squibb Company Information Table 202. Bristol-Myers Squibb Business Overview Table 203. Bristol-Myers Squibb General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 204. Bristol-Myers Squibb General Medicines Product Portfolio Table 205. Bristol-Myers Squibb Recent Development Table 206. Biogen Company Information Table 207. Biogen Business Overview Table 208. Biogen General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 209. Biogen General Medicines Product Portfolio Table 210. Biogen Recent Development Table 211. Argenx Company Information Table 212. Argenx Business Overview Table 213. Argenx General Medicines Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 214. Argenx General Medicines Product Portfolio Table 215. Argenx Recent Development Table 216. Key Raw Materials Table 217. Raw Materials Key Suppliers Table 218. General Medicines Distributors List Table 219. General Medicines Customers List Table 220. Research Programs/Design for This Report Table 221. Authors List of This Report Table 222. Secondary Sources Table 223. Primary Sources List of Figures Figure 1. General Medicines Product Image Figure 2. Global General Medicines Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global General Medicines Market Size (2021-2032) & (US$ Million) Figure 4. Global General Medicines Sales (2021-2032) & (K Units) Figure 5. Global General Medicines Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 General Medicines Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Over-the-Counter (OTC) Image Figure 9. Prescription (Rx) Image Figure 10. Global General Medicines Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global General Medicines Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global General Medicines Sales Market Share by Type (2021-2032) Figure 13. Global General Medicines Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global General Medicines Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global General Medicines Revenue Market Share by Type (2021-2032) Figure 16. Antihypertensives Image Figure 17. Antibiotics Image Figure 18. Antidiabetic Drugs Image Figure 19. Antipyretics Image Figure 20. Analgesics Image Figure 21. Others Image Figure 22. Global General Medicines Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global General Medicines Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global General Medicines Sales Market Share by Application (2021-2032) Figure 25. Global General Medicines Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global General Medicines Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global General Medicines Revenue Market Share by Application (2021-2032) Figure 28. North America General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America General Medicines Sales Market Share by Country (2021-2032) Figure 30. U.S. General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe General Medicines Sales Market Share by Country (2021-2032) Figure 35. Germany General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific General Medicines Sales Market Share by Country (2021-2032) Figure 42. China General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa General Medicines Sales Market Share by Country (2021-2032) Figure 50. Brazil General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile General Medicines Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global General Medicines Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global General Medicines Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America General Medicines Revenue (2021-2032) & (US$ Million) Figure 61. North America General Medicines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe General Medicines Revenue (2021-2032) & (US$ Million) Figure 63. Europe General Medicines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific General Medicines Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific General Medicines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa General Medicines Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa General Medicines Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. General Medicines Value Chain Figure 69. Manufacturing Cost Structure Figure 70. General Medicines Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Over-the-Counter (OTC)
  • Prescription (Rx)
Applications
  • Antihypertensives
  • Antibiotics
  • Antidiabetic Drugs
  • Antipyretics
  • Analgesics
  • Others
Companies covered
  • Sun Pharmaceutical
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Roche
  • Eli Lilly
  • Pfizer
  • Jiangsu Hengrui Medicine
  • Bayer
  • Amgen
  • AbbVie
  • AstraZeneca
  • Zoetis
  • Vertex Pharmaceuticals
  • Takeda Pharmaceutical
  • Seagen
  • Regeneron Pharmaceuticals
  • Novo Nordisk
  • Moderna
  • Lonza
  • Horizon Therapeutics
  • GlaxoSmithKline
  • Gilead Sciences
  • Daiichi Sankyō
  • CVS Health
  • Chugai Pharmaceutical
  • Bristol-Myers Squibb
  • Biogen
  • Argenx

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global General Medicines Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global General Medicines Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global General Medicines Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global General Medicines Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global General Medicines Market Dynamics
  1. 2.1 General Medicines Industry Trends
  2. 2.2 General Medicines Industry Drivers
  3. 2.3 General Medicines Industry Opportunities and Challenges
  4. 2.4 General Medicines Industry Restraints
3 General Medicines Market by Manufacturers
  1. 3.1 Global General Medicines Revenue by Manufacturers (2021-2026)
  2. 3.2 Global General Medicines Sales by Manufacturers (2021-2026)
  3. 3.3 Global General Medicines Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global General Medicines Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global General Medicines Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global General Medicines Manufacturers, Product Type & Application
  7. 3.7 Global General Medicines Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global General Medicines Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 General Medicines Players Market Share by Revenue in 2025
  11. 3.8.3 2025 General Medicines Tier 1, Tier 2, and Tier 3
4 General Medicines Market by Type
  1. 4.1 General Medicines Type Introduction
  2. 4.1.1 Over-the-Counter (OTC)
  3. 4.1.2 Prescription (Rx)
  4. 4.2 Global General Medicines Sales by Type
  5. 4.2.1 Global General Medicines Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global General Medicines Sales by Type (2021-2032)
  7. 4.2.3 Global General Medicines Sales Market Share by Type (2021-2032)
  8. 4.3 Global General Medicines Revenue by Type
  9. 4.3.1 Global General Medicines Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global General Medicines Revenue by Type (2021-2032)
  11. 4.3.3 Global General Medicines Revenue Market Share by Type (2021-2032)
5 General Medicines Market by Application
  1. 5.1 General Medicines Application Introduction
  2. 5.1.1 Antihypertensives
  3. 5.1.2 Antibiotics
  4. 5.1.3 Antidiabetic Drugs
  5. 5.1.4 Antipyretics
  6. 5.1.5 Analgesics
  7. 5.1.6 Others
  8. 5.2 Global General Medicines Sales by Application
  9. 5.2.1 Global General Medicines Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global General Medicines Sales by Application (2021-2032)
  11. 5.2.3 Global General Medicines Sales Market Share by Application (2021-2032)
  12. 5.3 Global General Medicines Revenue by Application
  13. 5.3.1 Global General Medicines Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global General Medicines Revenue by Application (2021-2032)
  15. 5.3.3 Global General Medicines Revenue Market Share by Application (2021-2032)
6 Global General Medicines Sales by Region
  1. 6.1 Global General Medicines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global General Medicines Sales by Region (2021-2032)
  3. 6.2.1 Global General Medicines Sales by Region (2021-2026)
  4. 6.2.2 Global General Medicines Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America General Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America General Medicines Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe General Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe General Medicines Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific General Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific General Medicines Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa General Medicines Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa General Medicines Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global General Medicines Revenue by Region
  1. 7.1 Global General Medicines Revenue by Region
  2. 7.1.1 Global General Medicines Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global General Medicines Revenue by Region (2021-2026)
  4. 7.1.3 Global General Medicines Revenue by Region (2027-2032)
  5. 7.1.4 Global General Medicines Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America General Medicines Revenue (2021-2032)
  8. 7.2.2 North America General Medicines Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe General Medicines Revenue (2021-2032)
  11. 7.3.2 Europe General Medicines Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific General Medicines Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific General Medicines Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa General Medicines Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa General Medicines Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sun Pharmaceutical
  2. 8.1.1 Sun Pharmaceutical Company Information
  3. 8.1.2 Sun Pharmaceutical Business Overview
  4. 8.1.3 Sun Pharmaceutical General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sun Pharmaceutical General Medicines Product Portfolio
  6. 8.1.5 Sun Pharmaceutical Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi General Medicines Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson General Medicines Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis General Medicines Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck General Medicines Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Roche
  32. 8.6.1 Roche Company Information
  33. 8.6.2 Roche Business Overview
  34. 8.6.3 Roche General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Roche General Medicines Product Portfolio
  36. 8.6.5 Roche Recent Developments
  37. 8.7 Eli Lilly
  38. 8.7.1 Eli Lilly Company Information
  39. 8.7.2 Eli Lilly Business Overview
  40. 8.7.3 Eli Lilly General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Eli Lilly General Medicines Product Portfolio
  42. 8.7.5 Eli Lilly Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer General Medicines Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Jiangsu Hengrui Medicine
  50. 8.9.1 Jiangsu Hengrui Medicine Company Information
  51. 8.9.2 Jiangsu Hengrui Medicine Business Overview
  52. 8.9.3 Jiangsu Hengrui Medicine General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Jiangsu Hengrui Medicine General Medicines Product Portfolio
  54. 8.9.5 Jiangsu Hengrui Medicine Recent Developments
  55. 8.10 Bayer
  56. 8.10.1 Bayer Company Information
  57. 8.10.2 Bayer Business Overview
  58. 8.10.3 Bayer General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bayer General Medicines Product Portfolio
  60. 8.10.5 Bayer Recent Developments
  61. 8.11 Amgen
  62. 8.11.1 Amgen Company Information
  63. 8.11.2 Amgen Business Overview
  64. 8.11.3 Amgen General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Amgen General Medicines Product Portfolio
  66. 8.11.5 Amgen Recent Developments
  67. 8.12 AbbVie
  68. 8.12.1 AbbVie Company Information
  69. 8.12.2 AbbVie Business Overview
  70. 8.12.3 AbbVie General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 AbbVie General Medicines Product Portfolio
  72. 8.12.5 AbbVie Recent Developments
  73. 8.13 AstraZeneca
  74. 8.13.1 AstraZeneca Company Information
  75. 8.13.2 AstraZeneca Business Overview
  76. 8.13.3 AstraZeneca General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 AstraZeneca General Medicines Product Portfolio
  78. 8.13.5 AstraZeneca Recent Developments
  79. 8.14 Zoetis
  80. 8.14.1 Zoetis Company Information
  81. 8.14.2 Zoetis Business Overview
  82. 8.14.3 Zoetis General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Zoetis General Medicines Product Portfolio
  84. 8.14.5 Zoetis Recent Developments
  85. 8.15 Vertex Pharmaceuticals
  86. 8.15.1 Vertex Pharmaceuticals Company Information
  87. 8.15.2 Vertex Pharmaceuticals Business Overview
  88. 8.15.3 Vertex Pharmaceuticals General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Vertex Pharmaceuticals General Medicines Product Portfolio
  90. 8.15.5 Vertex Pharmaceuticals Recent Developments
  91. 8.16 Takeda Pharmaceutical
  92. 8.16.1 Takeda Pharmaceutical Company Information
  93. 8.16.2 Takeda Pharmaceutical Business Overview
  94. 8.16.3 Takeda Pharmaceutical General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Takeda Pharmaceutical General Medicines Product Portfolio
  96. 8.16.5 Takeda Pharmaceutical Recent Developments
  97. 8.17 Seagen
  98. 8.17.1 Seagen Company Information
  99. 8.17.2 Seagen Business Overview
  100. 8.17.3 Seagen General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Seagen General Medicines Product Portfolio
  102. 8.17.5 Seagen Recent Developments
  103. 8.18 Regeneron Pharmaceuticals
  104. 8.18.1 Regeneron Pharmaceuticals Company Information
  105. 8.18.2 Regeneron Pharmaceuticals Business Overview
  106. 8.18.3 Regeneron Pharmaceuticals General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Regeneron Pharmaceuticals General Medicines Product Portfolio
  108. 8.18.5 Regeneron Pharmaceuticals Recent Developments
  109. 8.19 Novo Nordisk
  110. 8.19.1 Novo Nordisk Company Information
  111. 8.19.2 Novo Nordisk Business Overview
  112. 8.19.3 Novo Nordisk General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Novo Nordisk General Medicines Product Portfolio
  114. 8.19.5 Novo Nordisk Recent Developments
  115. 8.20 Moderna
  116. 8.20.1 Moderna Company Information
  117. 8.20.2 Moderna Business Overview
  118. 8.20.3 Moderna General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Moderna General Medicines Product Portfolio
  120. 8.20.5 Moderna Recent Developments
  121. 8.21 Lonza
  122. 8.21.1 Lonza Company Information
  123. 8.21.2 Lonza Business Overview
  124. 8.21.3 Lonza General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Lonza General Medicines Product Portfolio
  126. 8.21.5 Lonza Recent Developments
  127. 8.22 Horizon Therapeutics
  128. 8.22.1 Horizon Therapeutics Company Information
  129. 8.22.2 Horizon Therapeutics Business Overview
  130. 8.22.3 Horizon Therapeutics General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Horizon Therapeutics General Medicines Product Portfolio
  132. 8.22.5 Horizon Therapeutics Recent Developments
  133. 8.23 GlaxoSmithKline
  134. 8.23.1 GlaxoSmithKline Company Information
  135. 8.23.2 GlaxoSmithKline Business Overview
  136. 8.23.3 GlaxoSmithKline General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 GlaxoSmithKline General Medicines Product Portfolio
  138. 8.23.5 GlaxoSmithKline Recent Developments
  139. 8.24 Gilead Sciences
  140. 8.24.1 Gilead Sciences Company Information
  141. 8.24.2 Gilead Sciences Business Overview
  142. 8.24.3 Gilead Sciences General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Gilead Sciences General Medicines Product Portfolio
  144. 8.24.5 Gilead Sciences Recent Developments
  145. 8.25 Daiichi Sankyō
  146. 8.25.1 Daiichi Sankyō Company Information
  147. 8.25.2 Daiichi Sankyō Business Overview
  148. 8.25.3 Daiichi Sankyō General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Daiichi Sankyō General Medicines Product Portfolio
  150. 8.25.5 Daiichi Sankyō Recent Developments
  151. 8.26 CVS Health
  152. 8.26.1 CVS Health Company Information
  153. 8.26.2 CVS Health Business Overview
  154. 8.26.3 CVS Health General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  155. 8.26.4 CVS Health General Medicines Product Portfolio
  156. 8.26.5 CVS Health Recent Developments
  157. 8.27 Chugai Pharmaceutical
  158. 8.27.1 Chugai Pharmaceutical Company Information
  159. 8.27.2 Chugai Pharmaceutical Business Overview
  160. 8.27.3 Chugai Pharmaceutical General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Chugai Pharmaceutical General Medicines Product Portfolio
  162. 8.27.5 Chugai Pharmaceutical Recent Developments
  163. 8.28 Bristol-Myers Squibb
  164. 8.28.1 Bristol-Myers Squibb Company Information
  165. 8.28.2 Bristol-Myers Squibb Business Overview
  166. 8.28.3 Bristol-Myers Squibb General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Bristol-Myers Squibb General Medicines Product Portfolio
  168. 8.28.5 Bristol-Myers Squibb Recent Developments
  169. 8.29 Biogen
  170. 8.29.1 Biogen Company Information
  171. 8.29.2 Biogen Business Overview
  172. 8.29.3 Biogen General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  173. 8.29.4 Biogen General Medicines Product Portfolio
  174. 8.29.5 Biogen Recent Developments
  175. 8.30 Argenx
  176. 8.30.1 Argenx Company Information
  177. 8.30.2 Argenx Business Overview
  178. 8.30.3 Argenx General Medicines Sales, Price, Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Argenx General Medicines Product Portfolio
  180. 8.30.5 Argenx Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 General Medicines Value Chain Analysis
  2. 9.1.1 General Medicines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 General Medicines Production Mode & Process
  6. 9.2 General Medicines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 General Medicines Distributors
  9. 9.2.3 General Medicines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst